A sensory adaptation system that tunes chemoreceptor sensitivity enables motile Escherichia coli cells to track chemical gradients with high sensitivity over a wide dynamic range. Sensory adaptation involves feedback control of covalent receptor modifications by two enzymes: CheR, a methyltransferase, and CheB, a methylesterase. This study describes a CheR function that opposes the signaling consequences of its catalytic activity. In the presence of CheR, a variety of mutant serine chemoreceptors displayed up to 40-fold enhanced detection sensitivity to chemoeffector stimuli. This response enhancement effect did not require the known catalytic activity of CheR, but did involve a binding interaction between CheR and receptor molecules. Response enhancement was maximal at low CheR:receptor stoichiometry and quantitative analyses argued against a reversible binding interaction that simply shifts the ON-OFF equilibrium of receptor signaling complexes. Rather, a short-lived CheR binding interaction appears to promote a long-lasting change in receptor molecules, either a covalent modification or conformation that enhances their response to attractant ligands. bacterial chemotaxis | receptor methyltransferase | dynamic-bundle model | signaling conformation | nonequilibrium mechanism M otile bacteria, despite their small size and simple cellular architecture, track chemical gradients in their living environments with extraordinary precision (see refs. 1 and 2 for reviews). They do so with only a handful of different proteins organized in a sensory signaling network that has stimulus integration, amplification, and memory capabilities. The extensively studied chemotaxis machinery of Escherichia coli has provided the molecular paradigm for transmembrane and intracellular signaling mechanisms in microbial chemosensory systems. This report describes a long-unrecognized activity of a central component of the E. coli chemotaxis machinery, suggesting that there are important new molecular lessons to learn from this structurally simple, yet functionally sophisticated, signaling system. E. coli senses attractant and repellent chemicals with transmembrane chemoreceptors known as methyl-accepting chemotaxis proteins (MCPs) (3). MCPs form networked arrays of signaling complexes, typically at the cell poles, that produce highly sensitive and cooperative responses to small chemoeffector concentration changes. The four MCPs of E. coli (Tsr, Tar, Tap, and Trg) have a common functional architecture comprising a periplasmic sensing domain and a cytoplasmic signaling domain ( Fig. 1 ). An interposed HAMP domain communicates conformational changes between the sensing and signaling domains through an extended four-helix coiled-coil that contains sites for sensory adaptation adjustments of receptor signal output (4). The chemoreceptors modulate the activity of a histidine autokinase (CheA), which is stably coupled to receptors by a scaffolding protein (CheW). CheA donates its phosphoryl groups to CheY, a response regulator that in its phosphorylated form interacts with the basal bodies of the cell's flagellar motors to regulate their rotational behavior, producing locomotor responses. Phospho-CheY is short-lived, due to action of a dedicated phosphatase (CheZ), ensuring rapid swimming responses to chemoreceptor-triggered changes in CheA activity.
A sensory adaptation system that tunes chemoreceptor sensitivity enables motile Escherichia coli cells to track chemical gradients with high sensitivity over a wide dynamic range. Sensory adaptation involves feedback control of covalent receptor modifications by two enzymes: CheR, a methyltransferase, and CheB, a methylesterase. This study describes a CheR function that opposes the signaling consequences of its catalytic activity. In the presence of CheR, a variety of mutant serine chemoreceptors displayed up to 40-fold enhanced detection sensitivity to chemoeffector stimuli. This response enhancement effect did not require the known catalytic activity of CheR, but did involve a binding interaction between CheR and receptor molecules. Response enhancement was maximal at low CheR:receptor stoichiometry and quantitative analyses argued against a reversible binding interaction that simply shifts the ON-OFF equilibrium of receptor signaling complexes. Rather, a short-lived CheR binding interaction appears to promote a long-lasting change in receptor molecules, either a covalent modification or conformation that enhances their response to attractant ligands. bacterial chemotaxis | receptor methyltransferase | dynamic-bundle model | signaling conformation | nonequilibrium mechanism M otile bacteria, despite their small size and simple cellular architecture, track chemical gradients in their living environments with extraordinary precision (see refs. 1 and 2 for reviews). They do so with only a handful of different proteins organized in a sensory signaling network that has stimulus integration, amplification, and memory capabilities. The extensively studied chemotaxis machinery of Escherichia coli has provided the molecular paradigm for transmembrane and intracellular signaling mechanisms in microbial chemosensory systems. This report describes a long-unrecognized activity of a central component of the E. coli chemotaxis machinery, suggesting that there are important new molecular lessons to learn from this structurally simple, yet functionally sophisticated, signaling system. E. coli senses attractant and repellent chemicals with transmembrane chemoreceptors known as methyl-accepting chemotaxis proteins (MCPs) (3) . MCPs form networked arrays of signaling complexes, typically at the cell poles, that produce highly sensitive and cooperative responses to small chemoeffector concentration changes. The four MCPs of E. coli (Tsr, Tar, Tap, and Trg) have a common functional architecture comprising a periplasmic sensing domain and a cytoplasmic signaling domain ( Fig. 1 ). An interposed HAMP domain communicates conformational changes between the sensing and signaling domains through an extended four-helix coiled-coil that contains sites for sensory adaptation adjustments of receptor signal output (4) . The chemoreceptors modulate the activity of a histidine autokinase (CheA), which is stably coupled to receptors by a scaffolding protein (CheW). CheA donates its phosphoryl groups to CheY, a response regulator that in its phosphorylated form interacts with the basal bodies of the cell's flagellar motors to regulate their rotational behavior, producing locomotor responses. Phospho-CheY is short-lived, due to action of a dedicated phosphatase (CheZ), ensuring rapid swimming responses to chemoreceptor-triggered changes in CheA activity.
The gradient-tracking behavior of E. coli is made possible by a sensory adaptation system similar to those in many signal transduction systems of higher organisms (5, 6) . Receptor/CheW/CheA core complexes approximate two-state signaling devices, having a kinase-active (ON) state and a kinase-inactive (OFF) state. A change in ligand occupancy shifts the ON-OFF equilibrium to initiate a motor response. The adaptation system then introduces covalent changes at specific receptor residues to adjust coiled-coil packing interactions of the four-helix signaling bundle and restore the prestimulus ON-OFF equilibrium (7) . The adapted receptormodification state reflects the chemoeffector concentration that elicited the covalent change. Thus, sensory adaptation enables E. coli to follow spatial chemical gradients by making temporal comparisons of current chemoeffector levels to a short-term "memory" of the recent chemical past, recorded in the form of a receptor-modification state.
Two MCP-specific enzymes mediate sensory adaptation in E. coli, CheR, a methyltransferase that converts glutamyl (E) sites to glutamyl-methyl esters (Em), and CheB, a methylesterase that hydrolyzes Em sites to E sites (7) . The homodimeric serine chemoreceptor (Tsr) contains five adaptation sites per subunit (8, 9) , two of which are genetically encoded as glutaminyl (Q) residues, which mimic the signaling properties of Em sites (Fig.  1 ). CheB irreversibly deamidates such Q sites to E sites, creating two additional substrate sites for subsequent methylation and demethylation reactions. The relative activities of the opposing CheR and CheB enzymes govern the direction and extent of adaptational modifications. The system produces perfect adaptation over a wide range of chemoeffector concentrations through Significance Escherichia coli cells track chemical gradients with high sensitivity over a wide dynamic range, using a feedback-controlled sensory adaptation system. CheR, a receptor methyltransferase, is a key component of the adaptation system. We discovered that CheR can enhance the response sensitivity of chemoreceptor molecules, a role that opposes the known signaling consequences of its catalytic activity. This enhancement effect requires CheR-receptor binding interactions, but is quantitatively inconsistent with a simple equilibrium binding mechanism. Rather, CheR binding appears to promote a long-lasting conformational or covalent change that enhances the affinity of chemoreceptor molecules for their attractant ligands. The CheR response enhancement effect opens a new window on the functional architecture of chemoreceptor molecules and their interactions with sensory adaptation enzymes.
integral feedback control (10) (11) (12) : CheB operates preferentially on receptors in the ON state, shifting them toward OFF, whereas CheR operates preferentially on receptors in the OFF state, shifting them toward ON (Fig. 1) .
The structural differences between ON-state and OFF-state receptors that define the CheB and CheR substrate preferences are not well understood. Adaptation site residues lie on solventexposed helix faces and share a consensus nine-residue motif at which CheR and CheB must bind for catalysis (13) (14) (15) . Differences in higher-order structures of the methylation helix bundle presumably govern state-specific access to the substrate sites.
Those structural differences probably involve changes in substrate helix stability and changes in the packing interactions between helices of the methylation bundle (9, (16) (17) (18) (19) .
The critical sensory adaptation roles of the CheR and CheB enzymes have been known for decades (20) (21) (22) (23) (24) (25) . Here, we report that CheR has a second function that opposes the signaling consequences of its catalytic activity. We show that binding interactions between CheR and the receptor methylation helices produce this effect, but the CheR methyltransferase reaction plays no part. Rather, CheR binding seems to produce a longlasting structural change in receptor molecules, either a novel covalent modification or an altered native conformation that enhances their affinity for attractant ligands. The CheR response enhancement effect opens a new window on the functional architecture of chemoreceptor molecules and their interactions with sensory adaptation enzymes.
Results
Two CheR-Mediated Effects on Receptor Sensitivity. We followed control of CheA kinase activity in signaling complexes of the serine chemoreceptor Tsr with a FRET-based in vivo assay of interactions between the response regulator CheY, which obtains phosphoryl groups from CheA, and its phosphatase CheZ (26) . We compared Tsr detection sensitivity in an isogenic pair of strains, both of which lacked the CheB sensory adaptation enzyme. One strain (UU2567) also lacked the CheR adaptation enzyme (i.e., R − B − ); the other strain (UU2697) expressed functional CheR at its native cellular level (i.e., R + B − ). The serine dose-response data were fitted to a multisite Hill equation to obtain values for the response K 1/2 (the serine concentration that inhibits 50% of CheA activity), a measure of receptor sensitivity, and the (dimensionless) Hill coefficient, a measure of response cooperativity. The FRET assay also provides a value for the overall receptor-dependent kinase activity in the cells.
The conventional effect of the CheR methyltransferase on receptor sensitivity is illustrated in Fig. 2 , Upper. Wild-type Tsr subunits are translated with a [QEQEE] pattern of glutaminyl (Q) and glutamyl (E) residues at their five adaptational modification sites (Fig. 1 ). In Tsr dimers E sites bias receptor output toward a kinase-OFF state, whereas Q residues mimic methylated E sites (Em) and shift output toward a kinase-ON state (1, 9) . In UU2567 (R − B − ), wild-type Tsr subunits encoded by plasmid pPA114 or plasmid pRR53 retain their [QEQEE] residue pattern and produce a serine response with a K 1/2 of ∼17 μM. In UU2697 (R + B − ), CheR converts E sites to glutamyl-methylesters (Em), increasing the average methylation state of the Tsr molecules and raising their serine response K 1/2 to ∼50 μM ( Fig. 2, Upper) . Thus, CheR-mediated methylation shifts wild-type Tsr molecules toward the kinase-ON state and reduces the detection sensitivity of their response to serine.
Tsr molecules with a mutationally imposed [QQQQE] residue pattern at the adaptation sites have more on-shifted character than wild-type Tsr and exhibited a serine response K 1/2 of ∼160 μM in the UU2567 (R − B − ) host ( Fig. 2 , Lower). However, in the UU2697 (R + B − ) host, the Tsr [QQQQE] response K 1/2 was only ∼40 μM. Although Tsr [QQQQE] has one potential methylation site (E502) (8) , it is less reactive than the other four sites and undergoes little modification in UU2697 (R + B − ) (9). It appears, therefore, that CheR can enhance the response sensitivity of a receptor molecule that has little potential for CheRmediated modification. We refer to this paradoxical behavior as CheR-enhanced sensitivity. Note that wild-type Tsr [QEQEE] also seems to be subject to the CheR enhancement effect because its serine response K 1/2 in the CheR + host is comparable to that of Tsr [QQQQE], and evidently reflects a compromise between the ON-shifting effect of a higher methylation state and the OFF-shifting effect of CheR enhancement (Fig. 2) . White circles represent E residues capable of accepting methyl groups; gray circles represent Q residues that must be deamidated by CheB before they can be methylated by CheR. The C terminus of each subunit bears a pentapeptide sequence (NWETF) that serves to tether CheR in the vicinity of the adaptation sites. (Right) Structural interactions between the HAMP and methylation helix (MH) bundles predicted by the dynamic-bundle model of HAMP signaling (18) . The model assumes that chemoreceptors have two output signaling states (kinase-OFF; kinase-ON) but proposes that the ON-OFF equilibrium reflects shifts among multiple conformational states of the HAMP and MH bundles, whose packing stabilities are coupled in opposition by the phase stutter arrangement that joins their helices. Unmethylated adaptation sites (white circles) destabilize the MH bundle, allowing stronger HAMP packing. Methylated sites (black circles) stabilize the MH bundle, weakening HAMP packing. The HAMP-MH interplay poises the two bundles for stimulus responses: Attractants enhance HAMP stability to initiate a kinase-OFF output response; a subsequent methylation increase restores kinase-ON output during sensory adaptation. CheR preferentially acts on receptors in the OFF state; CheB preferentially acts on receptors in the ON state (1, 9) . AS1 (shown) and AS1′ are the N-terminal HAMP helices; AS2 and AS2′ (shown) are the C-terminal HAMP helices. MH1 and MH1′ (shown) are the N-terminal helices of the methylation bundle; MH2 (shown) and MH2′ are the C-terminal helices of the methylation bundle.
To explore the generality of the CheR enhancement effect, we compared the serine response sensitivities in UU2567 (R − B − ) and UU2697 (R + B − ) of Tsr variants that had different potentials for methylation by CheR ( Fig. 3 ). We observed the enhancement effect in receptors with as many as two to three available modification sites, some of which could readily undergo CheRmediated methylation. For example, Tsr-L263F, with a residue change at the C terminus of the HAMP AS2 helix ( Fig. 1 ), has a [QEQEE] adaptation site pattern and is a good substrate for CheR-mediated methylation (SI Appendix, Fig. S1 ), but nevertheless its response K 1/2 was about threefold lower in the UU2697 (R + B − ) host (∼200 μM) than in the UU2567 (R − B − ) host (∼700 μM) ( Fig. 3 and SI Appendix, Table S2 ). Similarly, Tsr-Q311M and Tsr-Q311P, with amino acid replacements at modification site 3 in the MH1 helix ( Fig. 1 ), undergo CheRmediated methylation (27) , but show more than a 10-fold increase in response sensitivity in the host containing CheR ( Fig. 3 and SI Appendix, Table S2 ). Receptors with as few as zero to one available modification sites also exhibited CheR-enhanced response sensitivity ( Fig. 3 ). For example, Tsr [NDNDX] receptors with various amino acid replacements at modification site 5 have no known CheR-modifiable sites: D mimics the signaling effects of E (and N mimics the signaling effects of Q), but D residues do not undergo CheR-mediated methylation (9, 28) . However, these receptors exhibited enhanced response sensitivity in the CheR-containing UU2697 (R + B − ) host ( Fig. 3 and SI Appendix, Table S2 ). Evidently, CheR-mediated methylation at any of the Tsr glutamyl residue modification sites is not essential for the response enhancement effect.
The K 1/2 values for the nine receptor variants that responded to serine in both hosts ( Fig. 3 and SI Appendix, Table S2 ) averaged about fourfold lower in the CheR-containing host (mean ratio = 0.23; SD = 0.11). The enhanced responses were less cooperative (mean ratio of Hill coefficients = 0.56 ± 0.34), but the prestimulus kinase activities in the two hosts were generally comparable (mean ratio of kinase activities = 1 ± 0.4).
Mechanistic Interpretation of CheR Response Enhancement. In terms of a two-state receptor model (29) , attractant stimuli and sensory adaptation shift receptor signaling complexes between a kinaseactivating (ON) state with low ligand affinity and a kinasedeactivating (OFF) state with high ligand affinity. Receptor molecules in the ON conformation are good substrates for CheB; receptor molecules in the OFF state are good substrates for CheR. Conceivably, the CheR enhancement effect might occur through CheR-receptor binding interactions that increase the equilibrium proportion of receptor signaling complexes in the OFF state. (See SI Appendix for an analysis of the affinity difference this equlibrium binding mechanism would require.)
This CheR equilibrium binding model predicts that the enhancement effect should scale with CheR levels in the cell. Moreover, because response enhancement occurs at the low native CheR:receptor stoichiometry, the receptors might need to be organized into assistance neighborhoods that allow the same CheR molecule to visit other nearby receptors (30, 31) . Enhancement might also depend on receptor molecules having the C-terminal pentapeptide (NWETF) that reversibly tethers CheR to the receptor neighborhood and thereby promotes its interaction with the substrate methylation site helices (32, 33) . Finally, we expected that the enhancement effect would not require CheR catalytic activity or any CheR-dependent methylation of the target receptor molecules. We tested these predictions in the following series of experiments.
The Tsr Response Enhancement Effect Scales with Intracellular CheR
Level. The native expression level of CheR is only about 140 molecules per cell and the stoichiometry of CheR to receptor dimers is ∼1:50 (34, 35) . We used a salicylate-inducible cheR expression plasmid (pPA810) to vary cellular CheR above Table S2 for parameter values.
the native level. Without induction, pPA810 complemented the chemotaxis defect of a cheR deletion mutant and expressed CheR at ∼1.5× the native level (SI Appendix, Fig. S2 ). CheR expression from pPA810 rose to ∼300× the native level at 0.8 μM salicylate induction ( Fig. 4 , Inset). To assess the influence of CheR expression level on the enhancement effect, we measured the response sensitivity of Tsr [QQQQE] in two Δ(cheRB) host strains carrying plasmid pPA810: (i) UU2902 expressed Tsr [QQQQE] from a compatible pRR53-derived plasmid and the FRET reporter proteins from inducible chromosomal genes; (ii) UU2915 expressed the FRET reporters from a compatible plasmid (pVS88) and Tsr [QQQQE] from the chromosomal tsr locus. These strain/plasmid combinations produced comparable results ( Fig. 4 ): The serine response K 1/2 was ∼10-fold lower in cells with uninduced pPA810 than in cells with no CheR (pKG116 vector control) ( Fig. 4 and SI Appendix, Table S3 ). With induction up to 0.8 μM salicylate, the K 1/2 declined approximately fourfold further. Thus, the magnitude of the response enhancement effect scales with cellular CheR level but is effectively saturated at only a few-fold above the native CheR: receptor stoichiometry.
CheR-Mediated Modification of Receptor Adaptation Sites Is Not
Required for the Effect. The receptor molecules in the CheR titration experiments above carried a known CheR methylation site, residue E502 (8, 9) . To explore the possibility that a low level of E502 modification by CheR might influence the response enhancement effect, we also tested Tsr [QQQQA], carrying an alanine replacement at E502. Tsr-E502A (i.e., a [QEQEA] adaptation site pattern) has signaling properties identical to those of wild-type Tsr ([QEQEE]) in hosts with various combinations of adaptation enzymes (SI Appendix, Fig. S3 ), but cannot undergo CheR-mediated methylation at residue 502 (27) . Tsr [QQQQA] showed response sensitivities similar to those of Tsr [QQQQE] over the tested range of CheR expression levels ( Fig.  4 and SI Appendix, Table S3 ).
Perhaps CheR has a previously unrecognized, enzymatic activity that can modify Tsr [QQQQA] receptors and shift their output toward the OFF state. We explored this possibility by comparing the electrophoretic mobilities of Tsr [QQQQA] subunits synthesized in cells lacking and containing CheR. Covalent modifications at MCP adaptation sites influence the mobility of receptor subunits in denaturing polyacrylamide gels (23, 36) . We observed no mobility shifts in Tsr [QQQQA] molecules from cells with high levels of CheR (SI Appendix, Fig. S4 ). This result rules out the possibility of CheR-mediated deamidation at adaptation sites 1-4 as well as any other covalent modification that detectably shifts receptor subunit mobility. It cannot exclude the possibility that CheR catalyzes a covalent modification of receptor molecules that has no effect on their electrophoretic mobility. Because methylation at E502 evidently plays no substantive role in CheR response enhancement, we used Tsr [QQQQE] to follow the effect in most subsequent experiments.
CheR-Tsr Binding Is Important for the Response Enhancement Effect.
The high-abundance receptors in E. coli (Tar and Tsr) have a conserved pentapeptide (NWETF) at their C-termini to which CheR binds with ∼2 μM affinity (33) ( Fig. 5 ). CheR probably binds to its substrate sites in the receptor methylation helices with lower affinity, because receptor molecules lacking the pentapeptide tether are inefficiently methylated (32) . Pentapeptide binding evidently increases the local concentration of CheR in the receptor cluster, enabling one CheR molecule to service groups of neighboring receptors (30, 31) . In addition, a structural comparison of apo and pentapeptide-bound forms of CheR suggested that CheR might undergo a conformational change, possibly of functional importance, upon binding the pentapeptide (37) .
To assess the contribution to the CheR enhancement effect of the C-terminal pentapeptide on receptor molecules, we compared the response sensitivities of Tsr variants with and without the NWETF pentapeptide. Tsr [QEQEE] ΔNWETF showed comparable response sensitivities in the UU2567 (R − B − ) and UU2697 (R + B − ) strains, confirming that the lack of the tether impairs CheR-promoted methylation of wild-type Tsr molecules (SI Appendix, Fig. S5 and Table S4 ). In Tsr [NDNDX] derivatives that undergo CheR-enhanced response sensitivity ( Fig. 3 ) deletion of the NWETF pentapeptide eliminated the enhancement effect (SI Appendix, Fig. S5 and Table S4 ), indicating that response enhancement depends on an interaction between CheR and the NWETF pentapeptide on the receptor molecule. That interaction might directly produce the enhancement effect or it might augment a low-affinity interaction between CheR and the methylation helices of the receptor that is more directly responsible for the effect. To distinguish these possibilities, we measured the response sensitivity of Tsr [QQQQE] ΔNWETF at different CheR expression levels ( Fig. 6 and SI Appendix, Table S5 ). The response sensitivity was similar in CheR-deficient cells (K 1/2 ∼ 240 μM) and in cells with a native level of CheR (K 1/2 ∼ 260 μM). However, high-level CheR expression partly compensated for the lack of a tether and enhanced response sensitivity (K 1/2 ∼ 50 μM), demonstrating that the NWETF pentapeptide is not essential to the effect. The tether most likely contributes to the response enhancement effect by promoting binding interactions between CheR and the substrate helices of receptor molecules.
The binding interaction between CheR and its substrate sites in receptor molecules depends on charge interactions between basic residues along one helical face in CheR and acidic residues at or near the receptor methylation sites (38, 39) ( Fig. 5 ). A Table S3 ). The solid lines are fits to the power function: Table S3 for parameter values.
glutamic acid replacement at CheR residue R53, a putative receptor-binding determinant (39) ( Fig. 5 ), eliminated the CheR enhancement effect ( Fig. 6 and SI Appendix, Table S5 ), consistent with the idea that response enhancement occurs through a binding interaction between CheR and the substrate helices of receptor molecules.
CheR Enzymatic Activity Is Not Needed for the Response Enhancement
Effect. The methyl donor for the receptor methylation reaction, the only known enzymatic activity of CheR, is S-adenosyl methionine (AdoMet) (40, 41) . If a CheR methylation reaction, for example at a heretofore undiscovered receptor site, were important for the response enhancement effect, we reasoned that the effect should be absent in cells starved of methionine, the precursor for AdoMet synthesis (41) . That was not the case: The CheR effect persisted in methionine-starved cells ( Fig. 6 and SI Appendix, Table S6 ), and control experiments confirmed that the starvation procedure had eliminated CheR-dependent receptor methylation (SI Appendix, Fig. S6 ). We conclude that the response enhancement effect does not require an AdoMet-dependent CheR enzymatic activity.
Residue D154 is a critical determinant for AdoMet binding by CheR (42) (Fig. 5 ). To ask whether AdoMet binding is required for the CheR enhancement effect, we constructed and characterized alanine and leucine replacement mutants at CheR-D154. Both mutant proteins were stably expressed, but failed to methylate Tsr [EEEEE] molecules (SI Appendix, Fig. S7 ). In dose-response tests with Tsr [QQQQE], neither CheR-D154A nor CheR-D154L produced much change in response sensitivity, even at the highest expression level tested ( Fig. 6 and SI Appendix, Table S6 ). Given that a CheR receptor-binding interaction is the basis for response enhancement, this result implies that amino acid replacements at residue D154 not only abrogate AdoMet binding, but also impair the receptor-binding conformation of CheR. As suggested by CheR structural studies (37, 42) , AdoMet binding to wild-type CheR may allosterically promote its receptor-binding conformation. Because depletion of AdoMet levels by methionine starvation did not prevent the CheR enhancement effect, S-adenosyl homocysteine (AdoHcy) might also allosterically activate CheR for receptor binding.
Cooperative Receptor Clustering Is Not Needed for the Response Enhancement Effect. CheR response enhancement occurs at native CheR:receptor stoichiometries (∼1:50), suggesting that each CheR molecule can influence multiple receptors, perhaps through successive binding visits to receptors in an assistance neighborhood or through binding to a receptor that is part of an extended, cooperative signaling team. To explore this issue, we asked whether a mutant CheW protein (CheW-X3: R117D/ E121R/F122S) defective in assembling cooperative receptor arrays (43) would abrogate CheR-enhanced response sensitivity. We measured serine responses in strain UU2961 (R − B − ), which expresses Tsr [QQQQE] and CheW-X3 from chromosomal loci and CheR and the FRET reporter proteins from compatible plasmids. Although the CheW-X3 cooperativity defect was evident in the dose-response behaviors, the CheR enhancement effect persisted (Fig. 7) . We conclude that CheR can boost receptor sensitivity in the absence of receptor clustering and high response cooperativity. Table S5 for parameter values. The effects of methionine starvation were measured in strain UU2967 [Δ(metF); R − B − ], which expresses Tsr [QQQQE] from the chromosomal tsr locus, and carried compatible plasmids for the FRET reporter proteins (pVS88) and for CheR (pPA810). One cell sample was starved for methionine (white symbols); a second sample was not (black symbols). See SI Appendix, Tables S5 and S6 for parameter values. (42)] were displayed with PyMol software. A few of the native residues at the N terminus (N) and C terminus (C) are not resolved in the crystal structure. Residue R53 (blue, space-filled) plays a role in recognition and binding of the substrate receptor helix (39); residue D154 (red, space-filled) hydrogen bonds with the hydroxyl groups of the ribose ring of the AdoMet methyl donor. The end product of the methyltransferase reaction (AdoHcy: gray, space-filled), is shown bound at the reaction site. Its sulfur atom (yellow, mostly hidden) indicates the location of the methyl group from AdoMet that is transferred to a receptor methylation site in the substrate helix (putative location indicated by the dashed circular outline). The receptor's C-terminal pentapeptide (NWETF) binds to a small auxiliary domain on CheR to tether the methyltransferase in the vicinity of its target substrates (33, 37) . The tether function can be supplied by a different, nearby receptor molecule (30, 31) .
The CheR Response Enhancement Effect Increases over Time in
Nongrowing Cells. All FRET dose-response experiments described above were done with cells taken from exponential growth conditions and placed in buffer. Given that successively higher intracellular CheR levels produced only modest increases in receptor sensitivity (Fig. 4) , the receptor molecules in such cells might be heterogeneous with respect to CheR enhancement, with a subpopulation that is relatively refractory to the effect. To explore this possibility, we treated UU2697 (R + B − ) cells with chloramphenicol to block new receptor synthesis and examined the subsequent time course of their CheR effect ( Fig. 8 and SI Appendix, Table S7 ). In the absence of new receptor synthesis, we found that the response K Fig. S8 ), implying that receptor molecules became more sensitive to the enhancement effect over time or that a transient CheR binding interaction produced a long-lasting change in receptor molecules that rendered them more sensitive to a serine stimulus. We make the case for this latter scenario in the Discussion.
Discussion
The CheR Response Enhancement Effect. We have found that both wild-type and mutant serine chemoreceptors exhibit substantially higher detection sensitivity in cells containing the receptor methyltransferase CheR than in cells lacking CheR. This response enhancement effect runs counter to the signaling effects of CheRmediated covalent modifications, which shift receptor molecules to a kinase-ON state and reduce their sensitivity to attractant ligands. The mechanism of CheR response enhancement is distinct from receptor methylation: It can occur with receptors that have no available modification sites and in methionine-starved cells that have little AdoMet, the methyl donor for the CheR methyltransferase reaction. However, the effect does seem to involve a binding interaction between CheR and the receptor. Tsr molecules lacking the C-terminal CheR-binding pentapeptide failed to show an enhancement effect at native CheR expression levels. The lack of a tether was offset to some extent at increased levels of CheR, indicating that the tether itself is not essential for the enhancement effect. Rather, it probably serves to increase local CheR concentration in receptor signaling complexes, likely promoting a binding interaction to the receptor methylation helices that directly produces the effect. Indeed, a mutant CheR protein defective in interacting with the receptor methylation helices did not produce response enhancement.
Difficulties with an Equilibrium Binding Mechanism for CheR Response
Enhancement. In the absence of CheR, equilibrium explanations for the serine-driven ON to OFF kinase activity switch in Tsr signaling complexes require that serine bind more tightly to the OFF state than to the ON state (44) (45) (46) . A simple extension of this equilibrium approach to encompass the CheR effect would require CheR binding to effectively enhance the serine affinity of the OFF state. The most straightforward way to accomplish this change in effective affinity would be to have CheR itself bind more tightly to the OFF state than to the ON state. At high expression levels, CheR promoted a roughly 40-fold drop in the response K 1/2 for serine. As illustrated in SI Appendix, a simple equilibrium explanation for the enhancement effect without cooperativity would require CheR to bind about 40-fold tighter to the OFF state than to the ON state.
There is both theoretical and experimental support for preferential substrate binding by CheR. Feedback control of the sensory adaptation process through differential recognition of receptor activity states is a critical feature of perfect adaptation models (10) (11) (12) . Moreover, in vivo and in vitro studies have shown that CheB, the methylesterase, acts on receptors that have a kinase-on state, whereas CheR operates on receptors that have a kinase-OFF state (reviewed in ref. 7) . The simplest basis for differential substrate recognition by the sensory adaptation enzymes would be preferential binding to receptors in the preferred signaling state (Fig. 1) . . Cells were then returned to tryptone broth containing no IPTG inducer and 500 μg/mL chloramphenicol to block further protein synthesis and incubated with shaking at 30°C. At various times thereafter, cells were removed for FRET experiments to measure their response K 1/2 to serine. Lines are best-fits to a singleexponential function. See SI Appendix, Fig. S8 for control data that show the effects of chloramphenicol treatment on intracellular Tsr levels and cell culture densities over the experimental time course. See SI Appendix, Table  S7 for parameter values.
The principal weakness in an equilibrium binding explanation for the CheR enhancement effect is that the cellular stoichiometry of CheR to receptors is only about 1:50 and yet the enhancement effect is nearly maximal at the native CheR expression level. Thus, in the absence of cooperativity, equilibrium binding interactions between CheR and only a small fraction of the cell's receptors would need to produce the effect. Cooperative interactions within a signaling array could conceivably amplify CheR action, but mutant cells with an array interface 2 lesion (CheW-X3) that disperses signaling complexes and diminishes response cooperativity still showed CheRenhanced responses (Fig. 7) . It follows that the equilibrium effect would need to act on individual signaling units because it does not depend on the amplification effects possible in a large cooperative array.
The fundamental chemoreceptor signaling unit consists of six receptor dimers (organized in two trimers of dimers), one CheA kinase dimer, and two molecules of CheW (47) . The asymmetric receptor interfaces in the core complex imply that not all six of the receptor dimers are functionally equivalent. If only one receptor of the core unit were recognized in the OFF signaling state, the stoichiometry of CheR to recognized receptor would be reduced from 1:50 to about 1:8, but this is still not enough to account for a nearly maximal enhancement effect at native CheR:receptor stoichiometry. It seems that the only scenario that could allow an equilibrium binding mechanism for the CheR effect would be if 80-90% of the cell's receptor molecules were not incorporated into signaling complexes and were also incapable of competing with the minority of functional receptors for CheR binding. Current understanding of the chemotaxis machinery makes this scenario implausible (48) (49) (50) (51) (52) .
A Possible Nonequilibrium Mechanism for CheR Response Enhancement.
The low native cellular stoichiometry of CheR to receptor molecules suggests that CheR might act in catalytic fashion to produce the enhancement effect. Although a binding interaction between CheR and the substrate helices of receptor molecules is important to the mechanism, the known catalytic activity of CheR is not. These properties argue against a CheR-catalyzed covalent modification, at any of the known adaptation sites, that acts in opposition to receptor methylation. Rather, the types of receptor alterations that potentiate the effect suggest an alternative mechanism. To date, we have observed CheR enhancement most clearly with mutant receptors that bear structural changes in the methylation site helices or in the adjoining HAMP domain (9, 27) . Structural changes in the receptor's hairpin tip region (Fig. 1 ) that produce a wide range of signaling behaviors did not potentiate the CheR effect (53) (54) (55) . Perhaps the receptor methylation helices, whose conformation and packing stability are under direct control by the HAMP domain, are central to the CheR effect. We suggest that in the absence of CheR, receptor molecules fold into a kinetically trapped structure that is not the most stable one possible. A CheR binding interaction at the methylation helices promotes the structural change needed to reach a more stable receptor conformation, one that has a higher binding affinity for attractant ligands.
We cannot yet say what the kinetically trapped and CheRcatalyzed receptor structures might be, but the essence of the mechanism is that the conversion is energy driven, using the higher free energy of the trapped form. Receptor conversion could involve a hitherto undiscovered covalent modification by CheR, but it is also possible to imagine ways in which CheR binding alone could assist a receptor conformational change. A plausible mechanism involving a shift in the relative stabilities of intra-and intersubunit packing interactions in the vicinity of the methylation helices is shown in Fig. 9 . Even if there is no appreciable reverse reaction, there is continual synthesis of new, unconverted receptor molecules in a CheR-containing cell, so it is also difficult to assess the steady-state number of converted receptor molecules. Con-sidering the lower cooperativity of CheR-enhanced responses, it seems likely that the receptor population is to some extent heterogeneous. This scenario predicts that the CheR effect should continue to enhance response sensitivity in cells that have ceased synthesizing new receptor molecules. Consistent with this prediction, the magnitude of the enhancement effect increased slowly over time in cells treated with chloramphenicol to block further protein synthesis ( Fig. 8 and SI Appendix, Table S7 ).
Biological Significance of CheR Response Enhancement. Modern-day chemoreceptors require the opposed signaling properties of the CheR and CheB sensory adaptation enzymes to track spatial chemical gradients with high precision and wide dynamic range (10) (11) (12) 56) . Conceivably, CheR response enhancement, which opposes the signaling effects of CheR-mediated receptor methylation, could have contributed to gradient-tracking behavior before the evolutionary advent of CheB, by enabling cells to detect and respond to low chemoeffector levels. In contemporary chemotaxis systems, where receptors have multiple methylation sites and undergo both methylation and demethylation reactions, the CheR effect might serve to optimally tune receptor sensitivity to different ambient chemoeffector concentrations.
A catalytic mechanism for the CheR enhancement effect raises a number of interesting experimental questions. Do CheR-conditioned receptor molecules show enhanced sensitivity in the absence of Fig. 9 . A possible nonequilibrium mechanism for the CheR enhancement effect. This model proposes that receptor dimers made in cells lacking CheR transition from four-helix coiled-coil packing at the hairpin tip to a stable packing arrangement between helices from the same subunit in the vicinity of the HAMP domain. Packing arrangements are indicated in helical wheel diagrams with shaded circles depicting the a (yellow) and d (green) heptad packing residues characteristic of coiled-coil helix interactions. Reversible CheR binding interactions with the methylation site helices might destabilize the intrasubunit twohelix structures, fostering a stable four-helix packing arrangement throughout the cytoplasmic signaling domain. The HAMP AS2 helices manipulate receptor output through their direct structural connection to the MH1 helices (4). The packing interactions of MH1 helices in the two-helix intrasubunit arrangement may resist HAMP manipulation to a greater extent than the CheR-converted four-helix form, accounting for the CheR response enhancement effect.
CheR? What is the structural difference between the two proposed receptor OFF states? Are receptor molecules able to reach the higher affinity conformational state without CheR assistance? These questions should be addressed in additional studies.
Experimental Procedures
Bacterial Strains and Plasmids. Strains used in this study were derivatives of E. coli K-12 strain RP437 (57) . Their relevant genotypes are listed in SI Appendix , Table S1 . The plasmids used in this work were: pKG116, a derivative of pACYC184 that confers chloramphenicol resistance and has a sodium salicylate-inducible expression/cloning site (58) ; pPA810, a derivative of pKG116 that carries cheR under salicylate control; pPA114, a derivative of pKG116 that expresses Tsr under salicylate control (59); pVS88, a derivative of pTrc99A that expresses CheY-YFP and CheZ-CFP under isopropyl-β-D-thiogalactopyranoside (IPTG)-inducible control (26) ; and pRR53, a derivative of pBR322 that expresses Tsr under IPTG control (59) .
Site-Directed Mutagenesis. Mutations in various plasmids were generated using Agilent QuikChange PCR Mutagenesis and verified by sequencing the entire coding region of the targeted genes, as previously described (59) .
Expression Levels of CheR Proteins. CheR expression from pPA810 was measured in strain UU2902; native CheR expression was measured in strain RP437. Cell samples were prepared as described by Li and Hazelbauer (34) and analyzed by SDS/PAGE and immunoblotting, as described previously (34, 54) . Briefly, cells were grown in tryptone broth (containing 12.5 μg/mL chloramphenicol and different concentrations of sodium salicylate inducer for pPA810 experiments) at 30°C to OD600 = 0.5. Cells (1 mL) were harvested and lysed by adding 200 μL of 50% (wt/wt) ice-cold trichloroacetic acid (TCA), incubating on ice for 15 min, and centrifuging for 15 min at 16,000 × g at 4°C. The TCA pellet was then washed by vortexing with 1 mL ice-cold acetone, centrifuged as before, air dried after discarding the supernatant, and resuspended in 100 μL SDS sample buffer. Native CheR samples were concentrated fivefold more than those from plasmid-expressed CheR samples. Immunoblots were incubated at room temperature overnight, using a 1:500 dilution of CheR antiserum provided by Ann Stock, University of Medicine and Dentistry of New Jersey, Newark, NJ, and Rutgers University, New Brunswick, NJ.
FRET-Based Measurement of in Vivo Kinase Activity. The assay protocol and data analysis followed the procedures previously described in detail (26, 60) .
Methionine Starvation Protocol. Strains with a ΔmetF mutation (UU2967 or UU2970) were grown and starved for methionine as described previously (41) . Briefly, cells were grown to OD600 = 0.5 in tryptone broth at 30°C, harvested by centrifuging at ∼1,100 × g for 6 min, washed twice with equal volumes of wash medium (10 mM potassium phosphate buffer at pH 7.0, 0.1 mM EDTA, 10 mM sodium lactate, and 0.1 mM each of threonine, leucine and histidine), and resuspended in an equal volume of wash medium. Cells were then incubated at 30°C with aeration for 60 min to starve them for methionine before use in FRET assays.
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SI Appendix A Two State Equilibrium Model for Receptor

Conformational Switching in the Presence of CheR
We assume that chemotaxis receptor signaling complexes can exist in an equilibrium between two states, the kinase-on (ON) or kinase-off (OFF) state. In addition we imagine that the receptor ligand (L) can reversibly bind to the ON or OFF state to form the ON potentially present at the vertices of a cube (Fig. 1 ).
Figure -
The eight states of the receptor (blue) in the presence of an attractant ligand (L) and CheR (R) that interconvert by twelve paths defined by pseudo first-order equilibrium constants (green).
Seven independent equilibrium constants are sufficient to define the equilibria among these eight species. The two-headed arrows shown as the edges of the cube define a total of twelve pathways that interconvert the eight states. Each edge is labeled with an equilibrium constant (for isomerizations) or as the product of an association constant and ligand concentration (for binding events where and
We define the six additional independent equilibrium constants as [2] [3]
[4]
[5]
[6]
[7]
The remaining equilibria shown in Figure 1 can be represented by equations 1-7. For example,
[8a]
and
[8b]
Using the 8 states, we can define the fraction of the receptors that are in the ON and OFF states:
[10] We assume that the value of K 1/2 observed in the array interface 2 mutant, where there are no cooperative interactions between core signaling units, reflects the condition that the fraction of core complexes in ON and OFF states is equal. The fact that these mutants show little liganddriven cooperativity in their dose response curves implies that, effectively, the signaling state of one receptor dominates the signaling state of the core unit so that [12] where L' equals K 1/2 . In the absence of CheR, this reduces to [13] and [14] because of the pathway independence of the equilibria shown in Figure 1 , [15] Under normal conditions, the ON state is favored in the absence of ligands so K 1 << 1 and K 2 >> 1 because the OFF state is favored when ligand is bound to the receptor, so [16] In the presence of CheR, we assume that there is no interaction between CheR binding and ligand binding, i.e., K 9 = K 11 and K 10 = K 12 . Arguments similar to the above for the CheR-free case give a solution for the value of L'', the ligand concentration at K 1/2 in the presence of CheR:
The ratio of the value of K 1/2 observed in the presence versus absence of CheR becomes [18] In the presence of saturating CheR, this becomes [19] So, in order for CheR to cause the 40-fold decrease in K 1/2 that we observed, CheR would have to bind 40 times more strongly to the OFF state than to the ON state (see Figure above ). Response data from in vivo FRET kinase assays were taken from (27) . Table S4 for parameter values. 3.6 ± 0.0 [2] 0.081 ± 0.037 [2] a Values with error ranges represent averages and standard deviations of [n] independent FRET-based dose-response experiments. Values below 10 were rounded to the nearest 0.1; values above 10 were rounded to the nearest 1; values above 100 were rounded to the nearest 10; values above 1000 were rounded to the nearest 100. b Absolute kinase activity was calculated from the FRET response to a saturating SER stimulus or, if no response, to KCN treatment (values in italics) (26, 60) . c Although Tsr wild-type [QEQEE] shows a higher K 1/2 in UU2697 (R+B-) than in UU2567 (R-B-), that response appears to be a compromise between the ON-shifting effect of a higher methylation state and the OFF-shifting effect of CheR enhancement. Note that in UU2697 the Tsr [QEQEE] K 1/2 is comparable to the Tsr [QQQQE] K 1/2 . NR: no response to 10 mM serine. FRET-based dose-response experiments. Values below 10 were rounded to the nearest 0.1; values above 10 were rounded to the nearest 1; values above 100 were rounded to the nearest 10. b Absolute kinase activity was calculated from the FRET response to a saturating SER stimulus. c Concentration of sodium salicylate inducer. experiments. Values below 10 were rounded to the nearest 0.1; values above 10 were rounded to the nearest 1; values above 100 were rounded to the nearest 10. b Absolute kinase activity was calculated from the FRET response to a saturating SER stimulus. nd: not determined. experiments. Values below 10 were rounded to the nearest 0.1; values above 10 were rounded to the nearest 1; values above 100 were rounded to the nearest 10.
Supplemental Figures
Fig. S4. Comparison of SDS-PAGE mobility of
